The Lab / Instrument 03
The pheromone evidence ledger
A study-by-study record of the controlled human research on candidate pheromone compounds. What the researchers tested, what they found, and whether anyone could reproduce it.
Last reviewed: 2026-10-29
No human pheromone has been conclusively identified. The most studied compounds — androstadienone and estratetraenol — show inconsistent, often irreproducible effects in laboratory settings and have not been shown to produce attraction or mate-choice effects under real-world conditions. MHC-based body-odour preference is the strongest and most replicated human chemosensory signal, but it is a broad odour signal, not a single compound. If you like pheromone cologne, buy it for the scent. The rest is the maker's marketing.
Compound verdicts
One plain-language call per compound, summarising the weight of evidence.
Androstadienone (AND) C₁₉H₂₄O
A steroid compound found in male sweat and seminal fluid. Probably the most studied candidate human chemosignal.
Some studies find AND affects women's mood, attention and cortisol in laboratory conditions, but results depend heavily on concentration, method of delivery, and who the experimenter is. Independent replications frequently fail or produce smaller effects. No study has shown behavioural effects (attraction, mate choice) under naturalistic conditions. AND is a chemosignal candidate, not a confirmed pheromone.
Estratetraenol (EST) C₁₈H₂₂O
A synthetic steroid sometimes claimed to be a female chemosignal, though its presence in typical human secretions is disputed.
Fewer than a dozen controlled human studies exist. A 2014 Science paper reported EST influenced motion-perception of gender-ambiguous stimuli in heterosexual men, which attracted wide coverage, but subsequent replications have produced inconsistent results. Whether EST is present in human bodily fluids at physiologically relevant concentrations is itself unclear. Evidence is currently weak.
Androstenone C₁₉H₂₈O
A steroid found in sweat and urine, first proposed as a human pheromone in the 1970s. About a third of people cannot smell it at all (specific anosmia).
Results across studies are highly inconsistent — some find women rate male attractiveness higher in the presence of androstenone, others find no effect or negative effects. Specific anosmia complicates all studies: roughly 30–35% of participants cannot detect androstenone, so effect sizes are diluted and hard to compare. No replicated behavioural effect exists.
Androstenol C₁₉H₃₀O
A fresh-sweat steroid (converted to androstenone by skin bacteria over time). Sometimes described as a short-term social-approach signal.
A handful of small studies (1970s–1990s) suggested androstenol promotes positive social evaluation, but modern replications are largely absent. The compound oxidises quickly to androstenone and therefore rarely reaches targets in a meaningful form in real-world contact. Evidence is very thin.
Copulins mixture
A mixture of volatile fatty acids in vaginal secretions. Proposed as a female pheromone based largely on animal studies.
Copulins raise testosterone in men in some studies, but effect sizes are small and the body of human research is tiny. Most relevant mechanistic evidence comes from rhesus macaques. No peer-reviewed study has demonstrated a reliable downstream behavioral effect in humans. Calling these pheromones in a human context is a significant extrapolation from animal data.
MHC / body-odour preference
The major histocompatibility complex (MHC) is a set of immune genes. Several studies have tested whether people prefer the body odour of MHC-dissimilar partners (the "T-shirt studies").
This is among the most consistently replicated chemosensory findings in humans: multiple independent groups have shown that people rate the body odour of MHC-dissimilar individuals as more pleasant or sexually attractive. However, effect sizes are moderate, the mechanism is unknown, oral contraceptives may reverse the preference, and it is not a pheromone in the strict sense — it is a general chemosensory cue, not a species-typical signal with a single dedicated receptor pathway.
Overall assessment
Expert reviews of the field as a whole.
The leading expert review (Wyatt 2015, Proceedings of the Royal Society B) concludes that no human pheromone has been conclusively identified. The field suffers from small samples, inconsistent delivery methods, publication bias, and insufficient focus on whether candidate compounds are actually present at physiologically relevant concentrations in human secretions. MHC-based body-odour preference is the strongest chemosensory signal found so far, but it is not a pheromone. This does not mean chemosignals don't exist — it means the evidence for the specific compounds sold in cologne isn't there yet.
Study table
17 entries covering key controlled studies and systematic reviews. Filter by compound. Source links go to the original publishers.
| Study | Year / n | Design | Finding | Replicated? |
|---|---|---|---|---|
| overview Wyatt, T.D. — "The search for human pheromones: the lost decades and the necessity of returning to first principles" | 2015 n=review | Systematic narrative review of the human pheromone literature. Proposes a first-principles framework: establish that a compound is in human secretions, characterise its receptor pathway, then test effects. | Concludes no human pheromone has been conclusively identified. The compounds most often studied (androstadienone, estratetraenol, androstenone) fail to meet criteria: their concentrations in human secretions are disputed or negligible, and behavioural effects are inconsistent across studies. | — |
| overview Liberles, S.D. — "Mammalian pheromones" | 2014 n=review | Annual Review of Physiology overview of mammalian vomeronasal and main olfactory pheromone systems, with a section on humans. | Notes that the human vomeronasal organ is vestigial and lacks functional neurons. Distinguishes well-characterised rodent pheromone circuits from the much weaker human evidence. Urges caution about applying the word "pheromone" to human chemosignals without receptor-level evidence. | — |
| androstadienone Jacob, S. & McClintock, M.K. — "Psychological state and mood effects of steroidal chemosignals in women and men" | 2000 n=40 (20 women, 20 men) | Double-blind, within-subjects. AND and androstenol applied under the nose; self-reported mood measured over 90 min. | AND maintained positive mood in women but not men; androstenol had no consistent effect. First well-cited controlled study of AND. | partialSome follow-up studies find mood or attention effects; others do not, especially those controlling for experimenter sex. |
| androstadienone Bensafi, M. et al. — "Androstadienone, a putative human chemosignal, affects performance on a focused attention task in women" | 2004 n=36 women | Double-blind, within-subjects. AND vs. carrier control applied under the nose. Participants completed a sustained-attention task and rated mood. | AND improved focused attention in women; self-reported mood effects were smaller and less consistent than attention effects. | partialAttention effects were replicated in one subsequent study but not in a larger pre-registered attempt. |
| androstadienone Hummer, T.A. & McClintock, M.K. — "Putative human pheromone androstadienone attunes the mind specifically to emotional information" | 2009 n=32 women | Double-blind, within-subjects. AND applied to upper lip; participants completed emotional attention tasks (dot-probe, facial expression). | AND increased accuracy on emotional-expression detection tasks in women. Authors interpret this as AND shifting cognitive resources toward socially relevant emotional cues. | partialFinding is conceptually consistent with the attention-effect literature but no direct replication with the same protocol has been published. |
| androstadienone Lundström, J.N. & Jones-Gotman, M. — "Romantic love modulates women's identification of men's body odors" | 2009 n=28 women | Within-subjects. Tested whether AND altered women's ability to identify their romantic partner's body odour. | AND exposure did not improve identification of a partner's odour, and did not affect ratings of attractiveness. Challenges some real-world implications of laboratory AND effects. | — |
| androstadienone Verhaeghe, J. et al. — "Androstadienone and etiocholanolone: mate-choice pheromones in women?" | 2013 n=112 | Pre-registered double-blind RCT. Women rated attractiveness of faces, voices and body odours after AND or control exposure. | No effect of AND on attractiveness ratings. One of the larger and better-powered studies in the AND literature; null result. | —This study is itself a partial replication attempt of earlier positive findings — result was null. |
| estratetraenol Zhou, W. et al. — "Chemosensory communication of gender through two human steroids in a sexually dimorphic manner" | 2014 n=24 heterosexual men, 24 heterosexual women, 24 bisexual/homosexual men | Within-subjects. Participants viewed a gender-ambiguous walking figure while AND or EST was presented orthonasally. Assessed whether compounds shifted gender attribution of the figure. | AND shifted gender perception toward male in women and gay/bisexual men; EST shifted it toward female in straight men. Attracted significant media coverage as evidence of sex-specific human chemosignals. | partialA larger pre-registered replication (Hütter et al. 2022, Psychological Science) failed to reproduce the EST-specific effect in straight men, though AND effects were partially reproduced. |
| estratetraenol Hütter, M. et al. — "The scent of sex: a pre-registered replication of the gender-signaling effects of two putative human sex pheromones" | 2022 n=390 (pre-registered) | Pre-registered direct replication of Zhou et al. (2014). Same stimuli, same protocol, large sample. | Failed to replicate the EST effect on gender perception in straight men. AND produced a small effect in women consistent with the original, but EST did not. Largest and most rigorous test of the Zhou 2014 claims. | —This study is the replication attempt. |
| androstenone Gustavson, A.R. et al. — "Androstenol, a putative human pheromone, affects human (Homo sapiens) male choice of female" | 1987 n=40 men | Double-blind; androstenone applied to a chair. Men's seat choices in a waiting room were recorded. | Men avoided chairs sprayed with androstenone. Consistent with the idea that high androstenone concentrations signal dominance/threat rather than attractiveness. | partialThe avoidance finding has some support from spacing studies, but attraction or mate-choice effects are not reliably replicated. |
| androstenone Cowley, J.J. & Brooksbank, B.W.L. — "Human exposure to putative pheromones and changes in aspects of social behaviour" | 1991 n=approx 30 per condition | Double-blind field study. Androstenone added to cubicles in a dental waiting room; patients' choices of where to sit and questionnaire ratings were measured. | Women but not men rated the cubicle as more "attractive" when it contained androstenone at a certain concentration. Effects were concentration-dependent and not seen in all conditions. | partialConcentration dependence has been replicated, but directional effects (more attractive vs. aversive) remain highly inconsistent across studies. |
| androstenol Kirk-Smith, M. et al. — "Human social attitudes affected by androstenol" | 1978 n=40 undergraduates | Double-blind. Androstenol applied to masks worn by participants; they rated photographs of people, animals, and architectural images. | Men wearing androstenol-treated masks rated photographs of women as more attractive. One of the earliest and most-cited androstenol studies. | partialSeveral 1980s–1990s studies found similar effects; no large-scale pre-registered replication exists. The effect direction (positive vs. neutral) is inconsistent. |
| copulins Grammer, K. — "5-alpha-androst-16en-3alpha-on: a male pheromone? A brief report" | 1993 n=66 men | Double-blind. Men rated female voice attractiveness and sexual arousal after copulin or control exposure. | Copulin exposure raised ratings of female voice attractiveness and self-reported arousal in some conditions. An early finding frequently cited by supplement marketers. | noNo independent group has published a replication of this specific finding. Sample and methods were not fully reported. |
| copulins Gap entry — no qualifying study exists | 2026 n=n/a | Gap in the record: this entry marks the absence of a well-powered, peer-reviewed, replicated human study demonstrating a clear copulin behavioural effect in humans as of 2026. | The copulin literature in humans consists largely of a single small 1993 study and animal-extrapolation papers. No peer-reviewed study published since 2000 meets modern methodological standards for a copulin behavioural effect in humans. | — |
| mhc Wedekind, C. et al. — "MHC-dependent mate preferences in humans" | 1995 n=49 women rating 44 men | Men wore T-shirts for two days; women rated pleasantness and sexiness of the odour. MHC types compared for rater–wearer pairs. | Women preferred the body odour of men with dissimilar MHC types, consistent with an immune-diversification mechanism for mate choice via smell. The original "T-shirt study". | yesMultiple independent groups have confirmed MHC-dissimilar odour preference in women (e.g. Wedekind & Füri 1997, Thornhill et al. 2003, Santos et al. 2005). Oral contraceptives appear to reverse the preference in some studies. |
| mhc Wedekind, C. & Füri, S. — "Body odour preferences in men and women: do they aim for specific MHC combinations or simply heterozygosity?" | 1997 n=65 women, 62 men | T-shirt study design; both sexes rated the other's odour. MHC typing used to test whether preference is for specific combinations or maximum heterozygosity. | Both men and women preferred MHC-dissimilar odours, suggesting mutual signalling. Dissimilarity rather than raw heterozygosity drove the preference. | yesConceptually replicated across cultures including European and Amazonian indigenous populations. |
| mhc Roberts, S.C. et al. — "MHC-correlated odour preferences in humans and the use of oral contraceptives" | 2008 n=97 women | T-shirt study. Women completed ratings before and after starting oral contraceptives; MHC dissimilarity compared across conditions. | Women not on oral contraceptives preferred MHC-dissimilar odours, as expected. Women on oral contraceptives showed the reversed preference (preferring MHC-similar odours). | partialThe contraceptive reversal finding is among the more reliable secondary effects in the MHC literature, but not all studies find a complete reversal. |
"Replicated" = at least one independent research group reproduced the core finding under comparable conditions. "Partial" = some but not all replication attempts succeeded. Source links open in a new tab; links go to publisher DOIs, not to paywalled PDFs.
Common questions
Do any human pheromones actually exist?
No human pheromone has been conclusively identified as of 2026. The most cited expert review (Wyatt 2015, Proceedings of the Royal Society B) concludes that the field has not yet demonstrated that any candidate compound — including androstadienone and estratetraenol, the two most studied — meets the criteria for a true pheromone.
What is androstadienone and does it work?
Androstadienone (AND) is a steroid found in male sweat and seminal fluid. Some laboratory studies have found it affects mood and attention in women under controlled conditions, but results are inconsistent and larger pre-registered replication attempts have returned null or small results. No study has shown it produces attraction or mate-choice effects under naturalistic conditions.
What does MHC have to do with body odour?
Several replicated studies show that people tend to find the body odour of MHC-dissimilar individuals more pleasant or sexually attractive, a finding consistent with immune-diversification in mate choice. This is the most consistently replicated human chemosensory finding, but it is a broad odour preference signal — not a single compound acting through a defined receptor pathway — so it does not meet the strict definition of a pheromone.
Should I buy pheromone cologne?
Buy pheromone cologne because you like how it smells. The evidence for the behavioural effects marketed on the bottle is weak or absent for every compound studied so far. Some products smell genuinely good; the fragrance is the value proposition.
How often is this ledger updated?
We review new publications and update rows when a significant new study or pre-registered replication is published. The last review date is shown in the page header.